Nordic Life Science 1
BUSINE S S D E A L ADDLIFE ACQUIRES TWO COMPANIES
AddLife has acquired the Irish company O’Flynn Medical and the German company BioCat. O’FLYNN MEDICAL is an independent distributor offering product sales, rental and technical services to the hospital sector, private customers and nursing homes in Ireland. The company will become part of the Healthcare 21 Group, which AddLife acquired in the business area Medtech in 2021. O’Flynn Medical has an annual net sales of approximately 6.4 million EUR and 36 employees. AddLife is also continuing its expansion in Europe by acquiring BioCat, for inclusion in its Labtech business area. BioCat has an annual revenue of 9 million EUR. The majority of the 20 employees work within sales and support. Kristina Willgård, CEO, AddLife